Cargando…
Using structural bioinformatics to investigate the impact of non synonymous SNPs and disease mutations: scope and limitations
BACKGROUND: Linking structural effects of mutations to functional outcomes is a major issue in structural bioinformatics, and many tools and studies have shown that specific structural properties such as stability and residue burial can be used to distinguish neutral variations and disease associate...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745591/ https://www.ncbi.nlm.nih.gov/pubmed/19758473 http://dx.doi.org/10.1186/1471-2105-10-S8-S9 |
_version_ | 1782171979403493376 |
---|---|
author | Reumers, Joke Schymkowitz, Joost Rousseau, Fréderic |
author_facet | Reumers, Joke Schymkowitz, Joost Rousseau, Fréderic |
author_sort | Reumers, Joke |
collection | PubMed |
description | BACKGROUND: Linking structural effects of mutations to functional outcomes is a major issue in structural bioinformatics, and many tools and studies have shown that specific structural properties such as stability and residue burial can be used to distinguish neutral variations and disease associated mutations. RESULTS: We have investigated 39 structural properties on a set of SNPs and disease mutations from the Uniprot Knowledge Base that could be mapped on high quality crystal structures and show that none of these properties can be used as a sole classification criterion to separate the two data sets. Furthermore, we have reviewed the annotation process from mutation to result and identified the liabilities in each step. CONCLUSION: Although excellent annotation results of various research groups underline the great potential of using structural bioinformatics to investigate the mechanisms underlying disease, the interpretation of such annotations cannot always be extrapolated to proteome wide variation studies. Difficulties for large-scale studies can be found both on the technical level, i.e. the scarcity of data and the incompleteness of the structural tool suites, and on the conceptual level, i.e. the correct interpretation of the results in a cellular context. |
format | Text |
id | pubmed-2745591 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27455912009-09-18 Using structural bioinformatics to investigate the impact of non synonymous SNPs and disease mutations: scope and limitations Reumers, Joke Schymkowitz, Joost Rousseau, Fréderic BMC Bioinformatics Research BACKGROUND: Linking structural effects of mutations to functional outcomes is a major issue in structural bioinformatics, and many tools and studies have shown that specific structural properties such as stability and residue burial can be used to distinguish neutral variations and disease associated mutations. RESULTS: We have investigated 39 structural properties on a set of SNPs and disease mutations from the Uniprot Knowledge Base that could be mapped on high quality crystal structures and show that none of these properties can be used as a sole classification criterion to separate the two data sets. Furthermore, we have reviewed the annotation process from mutation to result and identified the liabilities in each step. CONCLUSION: Although excellent annotation results of various research groups underline the great potential of using structural bioinformatics to investigate the mechanisms underlying disease, the interpretation of such annotations cannot always be extrapolated to proteome wide variation studies. Difficulties for large-scale studies can be found both on the technical level, i.e. the scarcity of data and the incompleteness of the structural tool suites, and on the conceptual level, i.e. the correct interpretation of the results in a cellular context. BioMed Central 2009-08-27 /pmc/articles/PMC2745591/ /pubmed/19758473 http://dx.doi.org/10.1186/1471-2105-10-S8-S9 Text en Copyright © 2009 Reumers et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Reumers, Joke Schymkowitz, Joost Rousseau, Fréderic Using structural bioinformatics to investigate the impact of non synonymous SNPs and disease mutations: scope and limitations |
title | Using structural bioinformatics to investigate the impact of non synonymous SNPs and disease mutations: scope and limitations |
title_full | Using structural bioinformatics to investigate the impact of non synonymous SNPs and disease mutations: scope and limitations |
title_fullStr | Using structural bioinformatics to investigate the impact of non synonymous SNPs and disease mutations: scope and limitations |
title_full_unstemmed | Using structural bioinformatics to investigate the impact of non synonymous SNPs and disease mutations: scope and limitations |
title_short | Using structural bioinformatics to investigate the impact of non synonymous SNPs and disease mutations: scope and limitations |
title_sort | using structural bioinformatics to investigate the impact of non synonymous snps and disease mutations: scope and limitations |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745591/ https://www.ncbi.nlm.nih.gov/pubmed/19758473 http://dx.doi.org/10.1186/1471-2105-10-S8-S9 |
work_keys_str_mv | AT reumersjoke usingstructuralbioinformaticstoinvestigatetheimpactofnonsynonymoussnpsanddiseasemutationsscopeandlimitations AT schymkowitzjoost usingstructuralbioinformaticstoinvestigatetheimpactofnonsynonymoussnpsanddiseasemutationsscopeandlimitations AT rousseaufrederic usingstructuralbioinformaticstoinvestigatetheimpactofnonsynonymoussnpsanddiseasemutationsscopeandlimitations |